Opinion
Medi-Cal access to anti-obesity medications is essential to Californians’ health
Health-focused semaglutide pens. Image by Eduardo Monroy HusillosOPINION – With the state finalizing their budget in the coming weeks and looking to fill deficits, including within the Medi-Cal program, AOM coverage could be on the chopping block. Having seen the importance of comprehensive obesity treatment with AOMs from a clinical standpoint, it’s imperative that this coverage isn’t cut